Kate is a principal and healthcare management consultant in the New York office of Milliman. She joined the firm in 1999.
Experience
Kate's expertise is in the intersection of disease processes, financing health benefits, and managing care. She leads teams of actuaries, benefits consultants, clinicians, and data analysts in projects for disease management companies, hospitals, employers, HMOs, pharmaceutical companies, and healthcare industry trade organizations. As project lead, she is instrumental in designing data analytics and communicating the implications for clients, as well as managing Milliman resources.
Kate leads projects that require analyzing quantitative and financial outcomes of therapies, processes, and care management - and converting these findings into measurable improvements in healthcare organizations' outcomes. Kate's role typically includes promoting these findings in organizations through reengineering, training and process improvement.
Recent projects have included evaluating disease management outcomes for commercial, Medicare and Medicaid populations; a variety of population-based cardiovascular risk studies; program assessments for care management processes; and inpatient process improvement at several hospitals focused on improved denial management and length of stay reduction.
Prior to joining Milliman, she worked for a case management company where she developed the company's case manager training and education program. Kate was previously an instructor in the nursing program at Columbia University School of Nursing. Prior to that, she was a research assistant at Memorial Sloane Kettering, where she was involved in nursing research studies. She also worked as a research assistant in pharmaceutical research studies at Roosevelt Hospital.
Kate's clinical background includes extensive experience as a registered nurse in emergency, adult inpatient, and ambulatory care units.
Presentations and publications
In addition to being a frequent speaker at industry events, Kate is author or co-author of numerous publicly-available reports, including Metabolic Syndrome and Employer Sponsored Benefits, Actuarial Impact of Ramipril Use in the Medicare Population Age 65+ at High Risk for Cardiovascular Events, End Stage Renal Disease: Who Pays?, Medicare Cost in Hospice and Non-Hospice Cohorts, Americans Are Getting Healthier, Controlling Hypertension Among Medicare Beneficiaries, and Obesity: A Big Problem Getting Bigger.
Education
BSN, Villanova University
MA, MEd Columbia University |